11/08/2024 Argaam Exclusive
Shares of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) hit an all-time high today, Aug. 11, at SAR 166.80.
The stock closed 1% lower at SAR 159.80 as about 230,000 shares changed hands.
Year High (SAR) | Year Low (SAR) |
166.80 | 100.20 |
Highest Since Debut (SAR) | Lowest Since Debut (SAR) |
166.80 | 66.00 |
Open | 150.60 |
Low | 148.00 |
High | 150.60 |
Previous Close | 150.60 |
Change (3M) | (14.77 %) |
Change (6M) | (5.66 %) |
Market Value | 10,381.00 |
Avg. Volume (3M) | 54,591.70 |
Avg. Turnover (3M) | 9,057,698.45 |
Avg. Transaction (3M) | 1,163.65 |
Change(12M) | (21.95 %) |
YTD | (2.56 %) |
Jamjoom Pharma has not amended its capital since listing on the Saudi Exchange (Tadawul) on June 20, 2023.
Date | Type | Capital (M Riyal) | Change (%) |
2023 | IPO | 700.00 | 0.00% |
Financial Ratio | Current |
Market Cap (M Riyal) | 10,381.01 |
Shares Outstanding ((M)) | 70.00 |
EPS ( | ) (TTM)6.22 |
Book Value (BV) ( Riyal) (Latest announcement) | 24.03 |
Recurring P/E | 23.83 |
Price/book | 6.17 |
Dividend Yield (%) (Last Year) | 2.06 |
Return on Average Assets (%) (TTM) | 22.36 |
Return on Average Equity (%) (TTM) | 27.70 |
Par Value ( Riyal) | 10.00 |
Enterprise Value (EV) (M Riyal) | 10,197.12 |
EV/adj EBITDA | 21.20 |
EV/Revenues | 7.08 |
Fair Average Price
Number of Recommendations
Rating | Research firm | Current Price | Target Price | Change | |
Buy | United Securities Company | 136.80 | 156.86 | 14.66 % |
Be the first to comment
Comments Analysis: